Offer - Urjas Oil for just ₹ 1 X
Tagat 0.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Tagat 0.25 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Tagat. If you are pregnant, do not take Tagat without a doctor's advice.
Is the use of Tagat 0.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Tagat. So it is adviced to consult the doctor before using it.
What is the effect of Tagat 0.25 Mg Tablet on the Kidneys?
Tagat rarely harms the kidneys.
What is the effect of Tagat 0.25 Mg Tablet on the Liver?
There may be severe side effects of Tagat on your liver. Do not take it unless a doctor says so.
What is the effect of Tagat 0.25 Mg Tablet on the Heart?
Side effects of Tagat rarely affect the heart.
Tagat 0.25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tagat 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Tagat 0.25 Mg Tablet habit forming or addictive?
You may get addicted to Tagat 0.25 Mg Tablet. Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tagat 0.25 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Tagat 0.25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, Tagat 0.25 Mg Tablet is useful in treating mental disorders.
Interaction between Food and Tagat 0.25 Mg Tablet
Tagat 0.25 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Tagat 0.25 Mg Tablet
Taking [medicine] and alcohol at the same time may lead to mild side effects. Contact your doctor right away if you observe any side effects.
Yes, [medicine] can cause stomach upset. It is a common side effect of it. Take light meals and avoid spicy and high-fat content meals when experiencing stomach upset while taking Tagat. In case of severe stomach upset consult your doctor, take medication and follow his/her instructions.
Tagat works by relaxing the muscles of the body and suppressing abnormal activity of nerve cells in the brain through increase in activity of a chemical messenger known as GABA. Thus, providing relief from sleeplessness and anxiety to the patient.
Tagat is a prescription drug so do not take it without consulting doctor. It can be harmful for the people to take this medicine without a doctor's advice.
Tagat is safe to use. Your doctor recommends this drug depending upon your condition and extends the medicine course further if you require it. Do not discontinue the treatment suddenly or take longer than prescribed.
Stopping or discontinuing Tagat on your own can cause withdrawal symptoms (seizures, difficulty in sleep, headache, nervousness, and depression). However, if you decide to stop/discontinue it, then stop it slowly, do not stop suddenly. However, please do not hesitate to discuss with your doctor if you are experiencing any withdrawal symptoms after stopping/discounting it on your own.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131